Ocular Physiology Clinical Trial
Official title:
Normative Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for the Measurements of Retinal and RNFL Thickness and Optic Disc Analysis
Verified date | January 2014 |
Source | Nidek Co. LTD. |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The purpose of this clinical study is to collect and evaluate the data from eye scans using an investigational three-dimensional eye imaging photography device called the Nidek Optical Coherence Tomography (OCT) RS-3000. OCT stands for Optical Coherence Tomography, a technique that uses invisible wavelengths of light to make detailed images of the tissues at the back of the eye. These images provide information that physicians may use to help diagnose eye conditions and/or to monitor changes in the eye during treatment.
Status | Completed |
Enrollment | 279 |
Est. completion date | August 2013 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Normal and healthy male and female subjects at least 20 years of age. Exclusion Criteria - Subjects who have extensive or debilitating systemic diseases. - Subjects who have significant ocular disease. - Subjects who are extremely far sighted or extremely near sighted. |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | UC San Diego, Hamilton Glaucoma Center, Department of Ophthalmology | La Jolla | California |
United States | USC Eye Institute, Keck Medical Center of USC | Los Angeles | California |
United States | UC Davis, Medical Center, Department of Ophthalmology & Vision Science | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
Nidek Co. LTD. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Development of age-specific normal ranges for the thickness of the retina and retinal nerve fiber layer (RNFL) and Optic Disc Analysis | The primary objective of this clinical study is to develop age-specific normal ranges for the thickness of the retina and retinal nerve fiber layer (RNFL)and Optic Disc Analysis. | Subjects will be followed for the duration of the procedure, up to one day. | No |
Secondary | Evaluation of adverse events found during the clinical study | The secondary objective is to evaluate any adverse events found during the clinical study. | Subjects will be followed for the duration of the procedure, up to one day. | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00431392 -
Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions
|
Phase 2 | |
Completed |
NCT06161012 -
Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear
|
N/A | |
Terminated |
NCT00708357 -
Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?
|
Phase 0 | |
Completed |
NCT05291936 -
Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear
|
N/A | |
Withdrawn |
NCT00712777 -
Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism
|
N/A | |
Completed |
NCT00709423 -
Effects of Moxaverine and Placebo on Ocular Blood Flow
|
Phase 2 | |
Completed |
NCT00708929 -
Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?
|
N/A | |
Completed |
NCT00712400 -
Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects
|
N/A | |
Completed |
NCT05427539 -
Feasibility Evaluation of Daily Disposable Toric Soft Contact Lenses Manufactured With an Alternative Hydration Process
|
N/A | |
Completed |
NCT05713552 -
Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative Lidstock
|
N/A | |
Withdrawn |
NCT00406731 -
Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure
|
Phase 2 | |
Completed |
NCT00706927 -
Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
|
N/A | |
Completed |
NCT00275730 -
Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers
|
N/A | |
Completed |
NCT00712764 -
Role of Adenosine in the Control of Choroidal Blood Flow During Changes in Ocular Perfusion Pressure.
|
N/A | |
Withdrawn |
NCT05530889 -
Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular Allergies
|
N/A | |
Completed |
NCT00312416 -
Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise
|
Phase 4 | |
Completed |
NCT00712907 -
Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow
|
N/A | |
Completed |
NCT00431730 -
Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?
|
N/A | |
Withdrawn |
NCT00991900 -
Short Term and Day to Day Reproducibility of Reflectometric Measurement of Retinal Oxygen Saturation in Healthy Subjects
|
||
Completed |
NCT00280501 -
Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions
|
N/A |